| 摘要 |
Preventives for reconstriction following coronary arterial intervention characterized by containing as the active ingredient a compound represented by formula (I). These drugs provide a novel use of preventing reconstriction after coronary arterial intervention of patients with anginal attack caused by coronary constriction of a high severity or patients with ischemic heart diseases for whom drug therapy is unapplicable. |
